DJ-1: A novel independent prognostic marker for survival in glottic squamous cell carcinoma

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1320-1325

  Zhu, Xiao Lin ^a,b   Wang, Zhang Feng ^a,b   Lei, Wen Bin ^a,b   Zhuang, Hui Wen ^a,b   Jiang, Hong Yan ^a,b   Wen, Wei Ping ^a,b  

^a First Affiliated Hospital   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOGENE PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953223169     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01531.x     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffier A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev 2006, 32:504-15.
3. Kleinsasser O. Revision of classification of laryngeal cancer; is it long overdue? (Proposals for an improved TN-classification). J Laryngol Otol 1992, 106:197-204.
4. Rumsby G, Carter RL, Gusterson BA. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer 1990, 61:365-8.
5. Scambia G, Catozzi L, Benedetti Panici P. Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br J Cancer 1994, 69:995-9.
6. Haughey BH, von Hoff DD, Windle BE, Wahl GM, Mock PM. A c-myc oncogene copy number in squamous carcinoma of the head and neck. Am J Otolaryngol 1992, 13:168-71.
7. Almadori G, Cadoni G, Maurizi M. Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections. Acta Otorhinolaryngol Ital 1995, 15(1 Suppl 46):1-22.
8. Jares P, Femandez PL, Campo E. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res 1994, 54:4813-7.
9. Motamed M, Banerjee AR, Bradley PJ, Powe D. MIB-1 and p53 expression in radiotherapy-resistant T1aN0M0 glottic squamous cell carcinoma. Clin Otolaryngol Allied Sci 2001, 26:227-30.
10. Gallo O, Santucci M, Franchi A. Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J Natl Cancer Inst 1997, 89:1161-3.
11. Yang YF, Gehrke S, Haque ME. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinoditol 3-kinase/ Akt signaling. Proc Natl Acad Sci U S A 2005, 102:13670-5.
12. Wei Y, Ringe D, Wilson MA, Ondrechen MJ. Identification of functional subclasses in the DJ-1 superfamily proteins. PloS Comput Biol 2007, 3:0120-6.
13. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 2004, 5:213-8.
14. Yokota T, Sugawara K, Ito K, Takahahi R, Ariga H, Mizusawa H. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 2003, 312:1342-8.
15. Zhang HY, Wang HQ, Liu HM, Guan Y, Du ZX. Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells. Endocr Relat Cancer 2008, 15:535-44.
16. Davidson B, Hadar R, Schlossberg A. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 2008, 39:87-95.
17. Liu H, Wang M, Li M. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun 2008, 375:477-83.
18. Yuen HF, Chan YP, Law S. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2008, 17:3593-602.
19. Kim RH, Peters M, Jang Y. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005, 7:263-73.
20. Junn E, Taniguchi H, Jeong BS, Zhao X, Mouradian MM. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci U S A 2005, 102:9691-6.
21. Shinbo Y, Taira T, Niki T, lguchi-Ariga SM, Ariga H. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol 2005, 26:641-8.
22. Clements CM, McNally RS, Conti BJ, Mak TW, Ting JP. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci U S A 2006, 103:15091-6.
23. Nagakubo D, Taira T, Kitaura H. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res 1997, 231:509-13.
24. MacKeigan JP, Clements CM, Lich JD, Pope RM, Hod Y, Ting JP. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 2003, 63:6928-34.
25. Hod Y. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 2004, 92:1221-3.
26. Le Naour F, Misek DE, Krause MC. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 2001, 7:3328-35.
27. Tian M, Cui YZ, Song GH. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008, 8:241.
28. Kristiansen G, Winzer KJ, Mayordomo E. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003, 9:4906-13.
29. TNM: Classification of Malignant Tumours 1997, Sobin LHWittekind C. eds, 5th ed, New York, NY, John Wiley & Sons Inc
30. Taira T, Takahashi K, Kitagawa R, lguchi-Ariga SM, Ariga H. Molecular cloning of human and mouse DJ-1 genes and identification of Sp1dependent activation of the human DJ-1 promoter. Gene 2001, 263:285-92.
31. Tillman JE, Yuan J, Gu G. DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Res 2007, 67:4630-7.
32. Zhang D, Lim SG, Koay ES. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma. Int J Oncol 2007, 31:577-84.
33. Pardo M, Garcia A, Thomas B. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 2006, 119:1014-22.